Decreased expression of angiogenesis antagonist EFEMP1 in sporadic breast cancer is caused by aberrant promoter methylation and points to an impact of EFEMP1 as molecular biomarker.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples